House of Commons report urges alignment with EU drug regulators

A U.K. House of Commons committee called on the U.K. to reach “regulatory alignment” with EMA on drug authorization and pharmacovigilance, and recommended exploring agreements with other countries or regions if alignment with EMA could not be reached. In its report,